» Articles » PMID: 36313178

Effects of Lycium Barbarum Polysaccharides on the Metabolism of Dendritic Cells: An Study

Overview
Journal J Immunol Res
Publisher Wiley
Date 2022 Oct 31
PMID 36313178
Authors
Affiliations
Soon will be listed here.
Abstract

Targeting dendritic cells (DCs) metabolism-related pathways and in-situ activation of DCs have become a new trend in DC-based immunotherapy. Studies have shown that polysaccharide can promote DCs function. This study is aimed at exploring the mechanism of LBP affecting DCs function from the perspective of metabolomics. MTT method was used to detect the activity of DC2.4 cells. ELISA kit method was used to detect the contents of IL-6, IL-12, and TNF- in the supernatant of cells. Ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF/MS) was used to detect general changes in DC2.4 cell metabolism. And then multidistance covariates and bioinformatics, partial least squares-discriminant analysis (PLS-DA) were used to analyze differential metabolites. Finally, metabolic pathway analysis was performed by MetaboAnalyst v5.0. The results showed that LBP had no significant inhibitory effect on the activity of DC2.4 cells at the experimental dose of 50-200 g/ml. LBP (100 g/ml) could significantly stimulate DC2.4 cells to secrete IL-6, TNF-, and IL-12. Moreover, 20 differential metabolites could be identified, including betaine, hypoxanthine, L-carnitine, 5'-methylthioadenosine, orotic acid, sphingomyelin, and L-glutamine. These metabolites were involved 28 metabolic pathways and the top 5 metabolic pathways were aspartate metabolism, pyrimidine metabolism, phenylacetate metabolism, methionine metabolism, and fatty acid metabolism. These results suggest that the effect of LBP on DCs function is related to the regulation of cell metabolism.

Citing Articles

Exploratory Research for HIF-1α Overexpression Tumor Antigen in the Activation of Dendritic Cells and the Potent Anti-Tumor Immune Response.

Zhao J, Zhang H, Zhao Y, Lin Z, Lin F, Wang Z Cancer Manag Res. 2024; 16:1813-1822.

PMID: 39713567 PMC: 11662640. DOI: 10.2147/CMAR.S482363.


Preliminary Exploration of Potential Active Ingredients and Molecular Mechanisms of Yanggan Yishui Granules for Treating Hypertensive Nephropathy Using UPLC-Q-TOF/MS Coupled with Network Pharmacology and Molecular Docking Strategy.

Yang F, Zhang K, Dai X, Jiang W J Anal Methods Chem. 2024; 2024:7967999.

PMID: 38766523 PMC: 11101260. DOI: 10.1155/2024/7967999.


Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers.

Xiong H, Han X, Cai L, Zheng H Front Oncol. 2023; 13:1274048.

PMID: 37876967 PMC: 10593453. DOI: 10.3389/fonc.2023.1274048.


Dietary Plant Polysaccharides for Cancer Prevention: Role of Immune Cells and Gut Microbiota, Challenges and Perspectives.

Wang A, Liu Y, Zeng S, Liu Y, Li W, Wu D Nutrients. 2023; 15(13).

PMID: 37447345 PMC: 10347129. DOI: 10.3390/nu15133019.

References
1.
Tel J, Schreibelt G, Sittig S, Mathan T, Buschow S, Cruz L . Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood. 2012; 121(3):459-67. DOI: 10.1182/blood-2012-06-435644. View

2.
Kikete S, Luo L, Jia B, Wang L, Ondieki G, Bian Y . Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity. Cytotechnology. 2018; 70(4):1097-1110. PMC: 6081929. DOI: 10.1007/s10616-018-0202-z. View

3.
Ness S, Lin S, Gordon J . Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease. Front Immunol. 2021; 12:633436. PMC: 7988082. DOI: 10.3389/fimmu.2021.633436. View

4.
Deng X, Luo S, Luo X, Hu M, Ma F, Wang Y . Polysaccharides from Chinese Herbal Induced Systemic and Local Immune Responses in H22 Tumor-Bearing Mice. J Immunol Res. 2018; 2018:3431782. PMC: 6008830. DOI: 10.1155/2018/3431782. View

5.
Cabeza-Cabrerizo M, Cardoso A, Minutti C, Pereira da Costa M, Reis e Sousa C . Dendritic Cells Revisited. Annu Rev Immunol. 2021; 39:131-166. DOI: 10.1146/annurev-immunol-061020-053707. View